Sioux Falls, SD, United States of America

Daniel W Vermeer

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Sanford Health. Active years: 2016-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel W Vermeer. Retrieved from https://idiyas.com/inventor/daniel-w-vermeer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Daniel W Vermeer

Introduction

Daniel W Vermeer is a notable inventor based in Sioux Falls, SD (US). He has made significant contributions to the field of biotechnology, particularly in the development of polynucleotides for treating oncogenic viral polypeptide positive tumors. With a total of 2 patents, his work is paving the way for advancements in cancer treatment.

Latest Patents

One of his latest patents focuses on polynucleotides that encode antigenic polypeptides to induce an immune response against oncogenic viral polypeptides. This patent outlines methods for treating tumors associated with viruses such as the human papilloma virus. The methods involve administering a composition that triggers an immune response, effectively targeting cells expressing oncogenic viral polypeptides like E6 and E7.

Career Highlights

Daniel W Vermeer is currently associated with Sanford Health, where he continues to innovate in the field of medical research. His work is instrumental in developing therapies that harness the body's immune system to combat cancer.

Collaborations

He collaborates with John H Lee, contributing to the advancement of their shared research goals.

Conclusion

Daniel W Vermeer is a prominent figure in the field of biotechnology, with a focus on innovative treatments for cancer. His contributions are vital for the future of oncological therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…